In addition, we observed that high CCDC25 level was significantly associated with shorter DFS and OS in the patients with HR+ subtypes but not in the patients with HR– breast cancer (Figure 6, D and E, and Supplemental Figure 10, C and D). The gene discussed is CCDC25; the disease is breast cancer.